CJC-1295 vs Ipamorelin: Canada Buyer’s Guide

CJC-1295 and Ipamorelin are two of the most searched growth hormone secretagogue peptides in Canada, and one of the most common questions is whether you should choose one or the other. The short answer is that they are not really rivals. They act on two different signalling pathways, and most research protocols pair them rather than pick a single one. This guide walks through what each peptide is, how they differ, and why the combination is the format most people actually order.

What CJC-1295 is

CJC-1295 belongs to the growth hormone releasing hormone (GHRH) analogue family. It mimics the body’s own GHRH signal, the message that tells the pituitary to produce growth hormone. The most widely studied research form is CJC-1295 without DAC (No DAC), sometimes called Modified GRF 1-29. Without the Drug Affinity Complex it clears from the system quickly and produces a short, pulse-shaped signal rather than a long flat elevation. That short pulse is exactly why it pairs so cleanly with a second peptide from a different class.

What Ipamorelin is

Ipamorelin is a growth hormone releasing peptide (GHRP) and a selective ghrelin receptor agonist. Instead of copying the GHRH signal, it works on the ghrelin pathway and also helps blunt somatostatin, the brake that normally limits growth hormone release. Ipamorelin is prized in research settings for being selective: it is known for triggering its target pathway without the strong knock-on effects on cortisol and prolactin seen with older, less clean GHRPs.

Side-by-side comparison

Why researchers pair them instead of choosing

The reason the two peptides are almost always studied together comes down to the two pathways working in complement. CJC-1295 raises the amount of growth hormone available to be released, while Ipamorelin opens the gate and eases the somatostatin brake. Acting on separate receptors, they are frequently described as synergistic in the literature: the combined signal is larger and more natural in shape than either compound produces on its own. This is why the market standard is a single blended vial rather than two separate purchases, and it is the format most Canadian buyers look for.

Choosing quality when you buy in Canada

Because these are two distinct molecules sold as one blend, purity and correct ratio matter more than usual. When comparing suppliers, look for identity and purity confirmed by HPLC and mass spectrometry, with a certificate of analysis available for the specific lot you receive. A blend is only as good as the weaker of its two components, so a per-lot COA is the single most useful thing to check before ordering.

Buying CJC-1295 and Ipamorelin from LYFE Science

LYFE Science stocks CJC-1295 (No DAC) + Ipamorelin as a ready blended vial, filed under our Signalling Research category alongside our other growth hormone secretagogue peptides. We are a Canadian supplier and ship coast to coast by Canada Post. Shipping is a flat $25 and free on orders over $150, with same-day dispatch on orders paid before noon Eastern and delivery to most of Canada in one to three business days. Packaging is plain and neutral. We accept Interac e-Transfer and crypto (BTC, ETH, SOL, USDC, USDT), and every lot is backed by a COA.

If you want to read up on peptide handling and storage first, our peptide guide covers the basics, and the full catalogue lives on the shop page. Ready to order the combo?

Buy CJC-1295 + Ipamorelin in Canada